Patients with mutations in the three genes not receiving perioperative platinum chemotherapy had worse OS than those who received such chemotherapy, although the difference did not reach statistical significance ( p = 0.07), possibly due to small numbers [ 46 ].
← all excerpts
The Landscape and Therapeutic Targeting of <i>BRCA1</i>, <i>BRCA2</i> and Other DNA Damage Response Genes in Pancreatic Cancer.
1
0.0700
0.0700